Canada markets open in 6 hours 1 minute

TFF Pharmaceuticals, Inc. (0K3.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.62500.0000 (0.00%)
As of 09:15AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 25.17M
Enterprise Value 13.05M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.51
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.38

Trading Information

Stock Price History

Beta (5Y Monthly) 1.21
52-Week Change 3-89.11%
S&P500 52-Week Change 3-10.89%
52 Week High 36.5000
52 Week Low 30.6100
50-Day Moving Average 30.7748
200-Day Moving Average 32.8477

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 536.19M
Implied Shares Outstanding 6N/A
Float 823.18M
% Held by Insiders 114.25%
% Held by Institutions 119.20%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sept 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-17,696.77%

Management Effectiveness

Return on Assets (ttm)-62.05%
Return on Equity (ttm)-104.75%

Income Statement

Revenue (ttm)195.02k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)75.20%
Gross Profit (ttm)-21.21M
EBITDA -34.17M
Net Income Avi to Common (ttm)-34.45M
Diluted EPS (ttm)-1.1600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.15M
Total Cash Per Share (mrq)0.51
Total Debt (mrq)208.15k
Total Debt/Equity (mrq)1.15
Current Ratio (mrq)8.18
Book Value Per Share (mrq)0.71

Cash Flow Statement

Operating Cash Flow (ttm)-30.52M
Levered Free Cash Flow (ttm)-19.13M